0001138723-20-000113.txt : 20201202 0001138723-20-000113.hdr.sgml : 20201202 20201202214153 ACCESSION NUMBER: 0001138723-20-000113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20201202 DATE AS OF CHANGE: 20201202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVINE JOSHUA CENTRAL INDEX KEY: 0001159917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33301 FILM NUMBER: 201365541 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCURAY INC CENTRAL INDEX KEY: 0001138723 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208370041 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 BUSINESS PHONE: 4087164600 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-11-30 0 0001138723 ACCURAY INC ARAY 0001159917 LEVINE JOSHUA 1310 CHESAPEAKE TERRACE SUNNYVALE CA 94089 1 1 0 0 President & CEO Common Stock 2020-11-30 4 A 0 280269 0.0 A 1045212 D Common Stock 2020-12-02 4 S 0 15674 4.0707 D 1029538 D Non-Qualified Stock Option (right to buy) 4.46 2020-11-30 4 A 0 527426 0.0 A 2030-11-30 Common Stock 527426 527426 D Fiscal year 2021 Performance award with two Performance Measurement Periods The first represents 40% of the grant and is from 7/1/2020 to 6/30/2021. The second represents 60% and is from 7/1/2021 to 06/30/2022. If the metrics are met for the first performance period vesting will commence quarterly beginning 9/30/2021 and ending 06/30/2023. If the metrics are met for the second performance period vesting will commence quarterly beginning 09/30/2022 and ending 06/30/2023. Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. 25% of the shares subject to such Option shall vest and be exercisable on the one-year anniversary of the Grant Date and an additional 1/48th of the original number of shares subject to such Option shall vest on the corresponding date of each month thereafter, subject to the applicable Grantee continuing to be a service provider through each such date. By: Brandy Green For: Joshua Levine 2020-12-02